Roblox Crashes After User Miss, Soft Guidance Triggers Wall Street Downgrades
Roblox shares plunged 21% in premarket trading in New York – the most in two years if losses hold through the cash session – after second-quarter users and bookings missed Bloomberg Consensus estimates, reflecting softer engagement following the rollout of new child-safety measures.
Daily active users reached 123 million versus the 128.7 million consensus, while bookings totaled $1.56 billion, below the $1.6 billion estimate. Roblox forecast third-quarter bookings of $1.58 billion to $1.65 billion, representing a 14% to 18% decline and missing the $1.87 billion projection.
Age-verification requirements and other protections introduced for minors on the platform, prompted by child exploitation concerns, have weighed on growth and monetization. Additionally, some parents are dialing back video game screen time for their children, as constant screen time is being viewed by some as detrimental to developmental health.
Roblox also withheld full-year guidance, citing greater variability and rising infrastructure costs tied to AI investments. The shares had already fallen about 40% this year through Thursday’s close.
Shares are down 21% in premarket trading.
“Contrary to our expectations, Roblox reported decelerating monetization, driven by UCAN and the U13 cohort. Q3 guidance was disappointing, and the withdrawal of FY26 guidance leaves visibility near zero. With this backdrop, we can no longer justify our positive stance here and are therefore downgrading to NEUTRAL. Monetization is soft while investment is rising, and beyond building better tools and incentives for developers to make more engaging, more monetizable 18+ content, much of the outcome is now out of Roblox’s hands,” Wedbush analyst Alicia Reese wrote in a note on Friday morning.
Here’s what other desks are saying (courtesy of Bloomberg):
Bloomberg Intelligence
- “Roblox’s 3Q bookings guidance at the high end is about 10% below consensus, showing that mandatory age checks for chat access and isolation of children’s accounts are weighing more than expected on near-term user growth and engagement”
BMO Capital Markets (cut to market perform from outperform, PT to $45 from $100)
- Roblox is continuing to face pressure in 2Q, as bookings seem set to decline in 3Q
- “Shifting engagement from high-monetizing viral games from 2025 into new and evergreen titles with lower hourly monetization drove a 2.5% Bookings miss in 2Q, as 3QE guidance was 12.5% below Street (midpoint) as RBLX removed 2026E guidance.”
Citi (buy, PT $70)
- The second-quarter report “looks solid,” but the third- quarter forecast is “well below the Street” * Vital Knowledge
- The results show “a miss on some key usage figures,” including daily active users and hours engaged, “and bookings growth was toward the low-end of guidance, while the Q3 bookings guidance fell short”
Spurs downgrades across Wall Street…
The average 12-month price target on the stock for Wall Street is around $57.29.
Tyler Durden Fri, 07/31/2026 – 07:45
Source: https://freedombunker.com/2026/07/31/roblox-crashes-after-user-miss-soft-guidance-triggers-wall-street-downgrades/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.



